The store will not work correctly when cookies are disabled.
4-Isopropyl-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-trione
ID: ALA4795502
PubChem CID: 162673449
Max Phase: Preclinical
Molecular Formula: C16H15NO3
Molecular Weight: 269.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)C1CC(=O)NC2=C1C(=O)C(=O)c1ccccc12
Standard InChI: InChI=1S/C16H15NO3/c1-8(2)11-7-12(18)17-14-9-5-3-4-6-10(9)15(19)16(20)13(11)14/h3-6,8,11H,7H2,1-2H3,(H,17,18)
Standard InChI Key: HNYPRKXVGMWFQK-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
28.3248 -10.2791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6119 -9.8650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3259 -11.1004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6117 -11.5107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6119 -12.3304 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3247 -12.7459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0348 -12.3315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0362 -11.5057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9055 -11.1022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9061 -10.2827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1972 -9.8722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4873 -10.2842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4907 -11.1068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2001 -11.5095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3239 -13.5672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.0324 -9.8662 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6085 -9.0437 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.7432 -11.0959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4516 -11.5033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7418 -10.2787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10 2 1 0
9 4 1 0
3 1 1 0
1 2 1 0
3 4 2 0
3 8 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
6 15 2 0
1 16 2 0
2 17 2 0
8 18 1 0
18 19 1 0
18 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 269.30 | Molecular Weight (Monoisotopic): 269.1052 | AlogP: 1.96 | #Rotatable Bonds: 1 |
Polar Surface Area: 63.24 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.57 | CX Basic pKa: ┄ | CX LogP: 1.84 | CX LogD: 1.84 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.79 | Np Likeness Score: 0.68 |
References
1. Wu LQ,Ma X,Zhang C,Liu ZP. (2020) Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents., 198 [PMID:32464425] [10.1016/j.ejmech.2020.112396] |